Ju Hyeon Oh

Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention

Joo‐Yong Hahn, Young Bin Song, Ju Hyeon Oh et al. · JAMA · 2019 · 588 citations · Full text

6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial

Joo‐Yong Hahn, Young Bin Song, Ju Hyeon Oh et al. · The Lancet · 2018 · 352 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +9

Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial

Bon‐Kwon Koo, Jeehoon Kang, Kyung Woo Park et al. · The Lancet · 2021 · 322 citations

Thrombosis, Percutaneous Coronary Intervention, Chronic Maintenance Monotherapy +11

Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial

Chan Joon Kim, Mahn‐Won Park, Min Chul Kim et al. · The Lancet · 2021 · 177 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +12

Ischemic Postconditioning During Primary Percutaneous Coronary Intervention

Joo‐Yong Hahn, Young Bin Song, Eun Kyoung Kim et al. · Circulation · 2013 · 166 citations · Full text